Zeroing out the individual mandate could suppress elective surgeries

In anticipation of the 2020 ending of the individual mandate penalizing Americans who don’t have health insurance, Harvard researchers have drawn from Massachusetts’s state-level reform experience to show a falloff in elective surgery is likely.

Radiation oncologist Daniel Kim, MD, MBA, radiologist Shahein Tajmir, MD, and colleagues had their findings published online Feb. 18 in the World Journal of Orthopedics.

The team calculated the rate of elective knee surgery in the orthopedic surgery department at Beth Israel Deaconess Hospital before and after healthcare reform featuring mandated coverage was enacted in Massachusetts in 2007 and nationally, via the Affordable Care Act (ACA), in 2010.

They found that the two years prior to any reform (2005-06) led into a period of increased utilization once the legislation took effect.

Specifically, where 8.07 percent of surgical candidates received elective knee surgery in the pre-reform period, 9.38 percent did so post-reform, a statistically significant jump.

In their discussion, the authors noted that the annual national spend for orthopedic care is nearly $850 billion, accounting for nearly 7.7 percent of GDP and affecting 77 million Americans.

President Donald Trump’s 2017 tax reform effectively ended the individual mandate. While Congress held off a full repeal of the mandate, it set the penalty at $0 starting in 2020.

“Given the similarity between the ACA and the mandated coverage stipulated by the Massachusetts law in 2007, this study provides insight into how the rate of elective orthopedic surgery may change nationally in light of the recent ruling against the ACA and the mandated coverage requirement,” Kim et al. concluded. “It is hypothesis generating and suggests avenues for further research into mandated coverage within Massachusetts and nationally.”

The study is available online in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup